At the start of May, we posted an update on clinical trials that were evaluating high dose biotin as a treatment for multiple sclerosis. Undertaken by biotechnology company, medDay, the results of these trials were presented at the recent American Academy of Neurology (AAN) Meeting in Vancouver, Canada. To learn more about the discoveries made, we recently interviewed Frédéric Sedel, MD, PhD, Chief Executive Officer of medDay.

If you have any questions relating to this discussion, please don’t hesitate to ask them below. Also, if you would like to review our earlier summary of the findings presented at the AAN Meeting in April 2016, it can be found here.

3 Responses

  1. Lina Di Marco

    Hello, I have PPMS and would like to know if high dosage Biotin can be prescribed by a family doctor.

    • MStranslate

      Hi Lina, thanks for the question. Currently, the high dose biotin formulation discussed in this interview is not available, as it has not yet received approval. Biotin is available over the counter in many countries as a supplement, however, it is generally not recommended in the doses that are being used in these trials.

      If you are interested in starting biotin as a way of potentially helping manage your PPMS, you should certainly discuss it with your neurologist or healthcare professional. We have heard anecdotal evidence from members of our community who have been using it under the advice of their doctor and have reported benefits. However, it is critical that you seek the advice of your doctor before starting any new treatment options.

      Hope this helps.

      Kind regards,


  2. Geoffroy

    I have spms and have taken 300mg/d biotin for at least 2 years under doctor supervision, first over the counter, then as the real medday stuff (available from hospitals in France). It did not work for me and finally my new neurologist (at hospital La Salpétrière where the medday team works) stopped it. She did not seem very impressed by the results reported by the medday team.


Leave a Reply

Your email address will not be published.